4d Molecular Therapeutics, Inc. · NASDAQ:FDMT
Janus Henderson Group PLC reported a 8.10% stake in 4d Molecular Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
Janus Henderson Group PLC reported a 8.10% stake in 4d Molecular Therapeutics, Inc., 4,635,875 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 8.10%
- Shares
- 4,635,875
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 8.10% | 4,635,875 |
Source
Related
- 4d Molecular Therapeutics, Inc.
- Janus Henderson Group PLC
- 4d Molecular Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Apr 7, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Feb 14, 2025
- Form 4 · Bizily Scott · Oct 20, 2026
- Form 4 · Kirn David · Oct 7, 2026
- Form 4 · Bizily Scott · Sep 22, 2026
- Form 4 · Kirn David · Sep 16, 2026
- Form 4 · Bizily Scott · Sep 3, 2026